Technology
Health
Biotechnology

Aptevo

$0.87
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-1.14%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Aptevo and other stocks, options, ETFs, and crypto commission-free!

About APVO

Aptevo Therapeutics Inc. Common Stock, also called Aptevo, is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics to improve patients lives. Read More Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.

Employees
118
Headquarters
Seattle, Washington
Founded
2016
Market Cap
39.68M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
340.41K
High Today
$0.88
Low Today
$0.8601
Open Price
$0.88
Volume
206.98K
52 Week High
$5.80
52 Week Low
$0.67

Collections

Technology
Health
Biotechnology
Therapy
2016 IPO
US
North America

APVO Earnings

-$0.63
-$0.53
-$0.42
-$0.32
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.